B+
Bull case
25%
Probability
Target price
$25.00
Analysis reference price unavailable
Analysis 2026-08-31 · RankAlpha Sentiment Codex
BBWI
Bath Body WorksBNYSE / Consumer Discretionary Distribution & Retail
Last Price
Quote time unavailable
AI scenario view
RankAlpha Sentiment CodexPost-earnings T+3Most likely
B
Base case
50%
Probability
Target price
$22.00
Analysis reference price unavailable
Analysis 2026-08-31 · RankAlpha Sentiment Codex
B-
Bear case
25%
Probability
Target price
$16.00
Analysis reference price unavailable
Analysis 2026-08-31 · RankAlpha Sentiment Codex
The current persistence contract does not provide an exact AI reference price. RankAlpha therefore does not calculate scenario return from the live quote. How scenarios are presented
AI sentiment snapshot
Latest data as of 2026-08-31
Recent news sentiment (30D)
-20.9
Negative
Company
+55.0
Positive
Macro
-21.2
Negative
Pulse
-
Unavailable
Weekly research (10D)
-
Unavailable
Sentiment proxy
+88.6
Score
AI commentary
The August 26 earnings release provides concrete primary-source support for the Q2 beat, raised FY26 EPS guidance, Direct-channel growth, and ongoing underlying pressure [#SEC-8K-2026-08-26]. Zacks reported a roughly 7.5% gain on August 27, while secondary analyst tracking showed broad target reductions that tempered the positive reaction. The packet's August 28 adjusted-close anchor is $19.22. Social, options, short-interest, and employee data are unavailable, so confidence remains moderate and the thesis is monitoring-oriented.
RankAlpha Sentiment Codex - 2026-08-31
Open post-earnings memoEvidence flagged
No evidence quality warning is currently attached to this memo.
Impact
standard
Confidence
-
AI events
2026-09-05catalystQ2 beat and raised FY26 EPS outlookHigh impact
Q2 sales were $1.514 billion, adjusted EPS was $0.62, and management raised adjusted FY26 EPS guidance from $2.40-$2.65 to $2.60-$2.80 while narrowing the sales-decline outlook from 4.5%-2.5% to 4%-2.5% [#SEC-8K-2026-08-26]. The benefit is partly offset by approximately $80 million of tariff refunds and continued underlying demand pressure.
2026-09-15eventPost-print reaction and analyst target cutsMedium impact
The SEC-filed earnings release confirms the Q2 beat, raised FY26 outlook, Direct-channel growth, and management's caution that underlying trends remain pressured [#SEC-SEC-8K-2026-08-26]. Zacks reported a roughly 7.5% share-price gain on August 27. Secondary analyst tracking recorded August 27 target cuts including Baird $25 to $23, Barclays $23 to $22, UBS $19 to $17, Wells Fargo $26 to $24, and Morgan Stanley $22 to $20, generally without rating changes. The reaction is constructive but vulnerable to skepticism about earnings quality and durability.
2027-01-31catalystTransformation proof points into 2027High impact
Management cited sequential Body Care improvement, stronger AUR on innovation, better brand discoverability, marketplace momentum, and first Direct net-sales growth since 2021, while acknowledging the transformation remains early [#SEC-8K-2026-08-26]. Sustained traffic, transactions, and organic margin improvement remain unconfirmed.
Recommendation
N/A
No formal recommendation provided.
As of 2026-08-31 • Updated nightlySource: Internal modelMethodology